[{"Assets_0_Q2_USD":14269000.0,"CommonStockSharesOutstanding_0_Q2_shares":6595509.0,"NetIncomeLoss_2_Q2_USD":-6903000.0,"NetIncomeLoss_1_Q2_USD":-4160000.0,"StockholdersEquity_0_Q2_USD":13270000.0,"Ticker":"SAVA","CIK":"1069530","name":"PAIN THERAPEUTICS INC","OfficialName":"Cassava Sciences Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"898902969.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170809"}]